Status of monkeypox testing in US ‘is very much a concern’: Global health expert
Published 11:00 AM, July 15, 2022
The White House plans to distribute more than one million monkeypox vaccine doses in the next few months. Public health experts are looking to the worldwide coronavirus response as a guide for what not to do this time around.
Thomas Bollyky, director of the global health program at the Council on Foreign Relations, said the United States has been very slow to roll out testing for the virus, which “is very much a concern.”
Bollyky said the U.S. government fortunately invested in vaccines that had been developed for smallpox and that received FDA approval to treat monkeypox after a small outbreak of the disease in the past. However, the country has been slow to obtain doses.
Compared to Covid-19, monkeypox is older, spreads less efficiently and kills far fewer people, he said.